Elsevier

Neuroscience

Volume 29, Issue 2, 1989, Pages 453-462
Neuroscience

5-Hydroxytryptamine demonstrated immunohistochemically in rat cerebrovascular nerves largely represents 5-hydroxytryptamine uptake into sympathetic nerve fibres

https://doi.org/10.1016/0306-4522(89)90072-9Get rights and content

Abstract

This study has re-examined, by immunohistochemistry, a proposed serotonergic innervation of major cerebral vessels in the rat. Previous studies had demonstrated a dense perivascular plexus of 5-hydroxytryptamine immunoreactive nerve fibres upon major cerebral vessels in this and many other species. The present work has shown, however, that 5-hydroxytryptamine immunoreactive nerve fibres are rarely observed in cerebral vessels prepared by perfusion-fixation in situ, and only form a well-developed plexus in vessels prepared, as in previous studies, by immersion-fixation. Prior treatment with a predominantly noradrenergic uptake inhibitor desmethylimipramine but not the serotonergic uptake inhibitor fiuoxetine produced a major diminution in the 5-hydroxytryptamine immunoreactive plexus visualized in these immersion-fixed vessels. In addition, 5-hydroxytryptamine immunoreactive nerves were only occasionally observed in immersion-fixed vessels from animals that had been pretreated with 6-hydroxydopamine to produce adrenergic denervation. The removal, firstly, of vessel-contained blood, by left ventricular perfusion with Krebs' solution, prior to vessel dissection and immersion-fixation, resulted in an absence of 5-hydroxytryptamine immunoreactivity in perivascular nerves. Immunoreactivity could then be restored by briefly incubating vessels in Krebs' solution containing either blood or 5-hydroxytryptamine before fixation. It would appear therefore that 5-hydroxytryptamine is rarely present under normal circumstances in the perivascular nerves of major cerebral vessels, and that previous descriptions of a dense serotonergic nerve plexus represent 5-hydroxytryptamine in blood released during vessel dissection being taken up via the noradrenaline-uptake system into perivascular sympathetic nerves.

The possibility is thus raised that 5-hydroxytryptamine uptake and interaction within perivascular adrenergic nerves could occur in those cerebrovascular disorders where blood is released.

Reference (42)

  • ScattonB. et al.

    Neurochemical studies on the existence, origin and characteristics of the serotonergic innervation of small pial vessels

    Brain Res.

    (1985)
  • ScheibelM.E. et al.

    Do raphe nuclei of the reticular formation have a neurosecretory or vascular sensor function

    Expl. Neurol.

    (1975)
  • SteinbuschH.W.M. et al.

    Localization of serotonin in the central nervous system by immunohistochemistry: description of a specific and sensitive technique and some applications

    Neuroscience

    (1978)
  • VerdouwP.D. et al.

    Redistribution of carotid artery blood flow by 5-HT: effects of the 5-HT2 receptor antagonists ketanserin and Wal 1307

    Eur. J. Pharmac.

    (1984)
  • AllenG.S. et al.

    Cerebral arterial spasm. Part I.In vitro contractile activity of vasoactive agents on canine basilar and middle cerebral arteries

    J. Neurosurg.

    (1974)
  • AnthonyM et al.

    The possible relationship of serotonin to the migraine syndrome

    Res. Clin. Stud. Headache

    (1969)
  • BaumgartenH.G.

    Biogenic monoamines in the cyclostome and lower vertebrate brain

    Prog. Histochem. Cytochem.

    (1972)
  • ChangJ.Y. et al.

    Immunohistochemical and pharmacological studies on serotonergic nerves and receptors in brain vessels

    Acta. physiol. scand.

    (1986)
  • ChangJ.Y. et al.

    Nerves containing serotonin. its interaction with noradrenaline and characterisation of serotonergic receptors in cerebral arteries of monkey

    J. Auton. Pharmac.

    (1987)
  • CowenT. et al.

    Pontamine sky blue: a counter stain for background autofluorescence in fluorescence and immunofluorescence histochemistry

    Histochemisiry

    (1985)
  • DahlstromA. et al.

    Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brainstem neurons

    Acta physiol. scand.

    (1964)
  • Cited by (0)

    View full text